Brady Statement on President Trump’s Plan on Drug Pricing

The following press release was published by the U.S. Congress Committee on Ways and Means on May 15, 2018. It is reproduced in full below.

Washington, D.C. - House Ways and Means Chairman Kevin Brady (R-TX) released the following statement regarding President Donald Trump’s plan to reduce the price of prescription drugs:

“I am encouraged to see President Trump leading the charge to enact policies that help lower drug prices. I look forward to reviewing these proposals and working together to continue making our health care system more affordable, competitive, and patient-centered."

Source: U.S. Congress Committee on Ways and Means